Pliant Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:PLRX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -37.27 M-75.44 M-94.63 M-116.36 M-155.5 M-128.34 M -98.7 M Cash from investing activities -210.87 M73.7 M-150.2 M-127.01 M140.34 M134.29 M 61.08 M Cash from financing activities 213.21 M2.53 M226.85 M274.4 M23.12 M-31.7 M -32.12 M Free cash flow -37.27 M-75.44 M-94.63 M-116.36 M-155.5 M-128.71 M -98.81 M

News

Pliant Therapeutics, Inc. (PLRX) Presents at AACR Annual Meeting 2026 - Slideshow (NASDAQ:PLRX) 2026-04-21

Piper Sandler cuts Pliant Therapeutics stock price target to $3

Stock Picks From Seeking Alpha's February 2026 New Analysts

Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration

Pliant therapeutics CFO Cummings sells $30,722 in stock

Pliant Therapeutics CHRO Cheung sells $9.6k in stock

Pliant Therapeutics appoints Minnie Kuo as chief operating officer

Pliant Therapeutics, Inc. (PLRX) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:PLRX) 2025-12-09

Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre

Pliant Therapeutics stock jumps on promising cancer drug trial results

Why Is Pliant Therapeutics Stock Trading Lower Today - Pliant Therapeutics (NASDAQ:PLRX)

Pliant’s PLN-101095 shows promising results in cancer trial